Navigating the recent growth in asthma medications The National Asthma Council Australia has launched new resources to help inform health professions about treatment options.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
Research provides new blueprint for chronic pain care The framework promotes person-centred care and aims to support clinicians treating the one in five Australians living with chronic pain.
Research shows medicinal cannabis ‘boom’ in Australia More than 248,000 prescriptions have been approved over the past five years – 85% of which have been given out since January 2020.
Key updates to ‘living’ stroke guidelines The first major update since 2018 contains several new strong recommendations for the management of stroke.
‘So many positives’ at PONC 2022 Hundreds of GPs and practice managers attended a massive Practice Owners National Conference in Hobart over the weekend.
Update to national asthma guidelines The Australian Asthma Handbook V2.2 includes information on exercise-induced bronchoconstriction, vaping and newly available medications.
COVID treatment update: Answers to what HPs are asking NPS MedicineWise speaks with members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group, who provide an update on the new antiviral treatments and answer some frequently asked questions.
Chronic non-cancer pain in older people Dr David Liew talks with clinical pharmacology registrar Dr Gloria Wong about some of the challenges involved in the pharmacological management of chronic non-cancer pain in frail older people.
‘Direct advocacy’ sees accreditation extended for flood-affected Accredited general practices that are up for review will be eligible to receive an extension of up to 12 months, allowing them to focus on rebuilding.